150 related articles for article (PubMed ID: 195378)
1. A new myasthenic syndrome with end-plate acetyl cholinesterase (AChE) deficiency, small nerve terminals, and reduced acetylcholine release.
Engel AG; Lambert EH; Gomez MR
Trans Am Neurol Assoc; 1976; 101():11-5. PubMed ID: 195378
[No Abstract] [Full Text] [Related]
2. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
Engel AG; Lambert EH; Gomez MR
Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
[TBL] [Abstract][Full Text] [Related]
3. End-plate acetylcholinesterase deficiency associated with small nerve terminals and reduced acetylcholine release. A new syndrome.
Engel AG; Lambert EH; Gomez MR
Int J Neurol; 1980; 14(1):73-86. PubMed ID: 6293992
[No Abstract] [Full Text] [Related]
4. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
5. Exercise effects on recovery of muscle acetylcholinesterase from reduced neuromuscular activity.
Gardiner PF; Lapointe M; Gravel D
Muscle Nerve; 1982; 5(5):363-8. PubMed ID: 6289098
[TBL] [Abstract][Full Text] [Related]
6. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
[TBL] [Abstract][Full Text] [Related]
7. Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.
Engel AG; Nagel A; Walls TJ; Harper CM; Waisburg HA
Muscle Nerve; 1993 Dec; 16(12):1284-92. PubMed ID: 8232383
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
Struppler A; Ruprecht EO
Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
[No Abstract] [Full Text] [Related]
9. Inhibition of human motor endplate cholinesterase by anticholinesterase compounds.
Fujii M; Namba T
Acta Med Okayama; 1982 Jun; 36(3):229-32. PubMed ID: 7113748
[TBL] [Abstract][Full Text] [Related]
10. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
[TBL] [Abstract][Full Text] [Related]
11. Abnormal neuromuscular transmission in an infantile myasthenic syndrome.
Albers JW; Faulkner JA; Dorovini-Zis K; Barald KF; Must RE; Ball RD
Ann Neurol; 1984 Jul; 16(1):28-34. PubMed ID: 6087719
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative estimation of synaptic acetylcholinesterase inhibition with galanthamine using parameters of miniature endplate currents].
Krivoĭ II
Biull Eksp Biol Med; 1988 Jun; 105(6):665-7. PubMed ID: 3390582
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of acetylcholine receptors in a case of end-plate acetylcholinesterase deficiency: a histochemical investigation.
Jennekens FG; Hesselmans LF; Veldman H; Jansen EN; Spaans F; Molenaar PC
Muscle Nerve; 1992 Jan; 15(1):63-72. PubMed ID: 1732764
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
16. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
Engel AG
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
Kelly JJ; Lambert EH; Lennon VA
Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
[TBL] [Abstract][Full Text] [Related]
19. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance.
Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J
Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683
[TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]